Ionic Capital Management’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Ionic Capital Management’s Portfolio SRTAW Stock Details SRTAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-371,749	Closed	-$130K	–	154
2023 Q4	$130K	Sell	371,749 -119,434	-24%	-$34.1K	0.03%	128
2023 Q3	$113K	Sell	491,183 -311,072	-39%	-$146K	0.03%	149
2023 Q2	$508K	Hold	802,255	–	–	0.15%	112
2023 Q1	$389K	Hold	802,255	–	–	0.11%	117
2022 Q4	$401K	Buy	802,255 +40,309	+5%	+$25.8K	0.1%	157
2022 Q3	$488K	Sell	761,946 -25,717	-3%	-$21.8K	0.07%	216
2022 Q2	$528K	Sell	787,663 -39,552	-5%	-$60K	0.06%	206
2022 Q1	$1.68M	Sell	827,215 -37,187	-4%	-$58.5K	0.19%	136
2021 Q4	$1.91M	Buy	864,402 +93,991	+12%	+$230K	0.24%	119
2021 Q3	$2.3M	Sell	770,411 -33,335	-4%	-$69.7K	0.29%	102
2021 Q2	$2.2M	Buy	803,746 +140,095	+21%	+$305K	0.23%	124
2021 Q1	$1.66M	Buy	+663,651	New	+$2.43M	0.21%	115

Other funds holding SRTAW

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return

TPCW

TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ionic Capital Management's SRTAW Position: Q1 2024 in Review

Ionic Capital Management sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q1 2024, closing a stake of 371,749 shares — an estimated $130K sold.

Ionic Capital Management first reported a position in SRTAW in Q1 2021 and held it in 12 quarters. The position peaked at $2.3M in Q3 2021. 11 funds tracked by Wall St. Rank hold SRTAW as of Q1 2024.

Ionic Capital Management reported no remaining Strata Critical Medical Inc Warrants position as of Q1 2024 after selling out during the quarter.
Ionic Capital Management sold 371,749 Strata Critical Medical Inc Warrants shares in Q1 2024, an estimated $130K.
Ionic Capital Management first reported a position in Strata Critical Medical Inc Warrants in Q1 2021 and held it in 12 quarters.
Ionic Capital Management's Strata Critical Medical Inc Warrants position peaked at $2.3M in Q3 2021.
11 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q1 2024.

Based on Ionic Capital Management's 13F filing for Q1 2024, filed 15 May 2024.